Xbira 250mg Tablets: Product Details
Xbira 250mg Tablets are associated with the active ingredient abiraterone acetate, an androgen biosynthesis inhibitor. Please verify the composition and strength against the actual product packaging and official product documentation before relying on this information.
Brand name: Xbira
Strength: 250mg
Dosage form: Oral tablets
Active ingredient: Abiraterone acetate, subject to product verification
Therapeutic category: Oncology
Primary treatment area: Certain forms of prostate cancer
Supply status: Subject to prescription, registration, and applicable import requirements
Abiraterone acetate is generally prescribed alongside prednisone or prednisolone and androgen deprivation therapy, depending on the patient's diagnosis and treatment plan. It must be used under specialist medical supervision.
Benefits and Uses of Xbira 250mg Tablets
Abiraterone acetate works by inhibiting CYP17, an enzyme involved in androgen production. Androgens, including testosterone, can stimulate the growth of prostate cancer cells. Reducing androgen production can therefore help control the disease in appropriate patients.
Potential clinical benefits include:
Prostate cancer management: Used for specific indications in advanced prostate cancer.
Hormonal treatment approach: Reduces androgen production through a targeted mechanism.
Combination therapy: May form part of a specialist-directed treatment regimen.
Ongoing disease management: Can help manage eligible patients when prescribed according to approved clinical indications.
Treatment response varies between patients. Xbira should not be described as a cure, and its suitability must be determined by an oncologist.
Possible Side Effects of Xbira 250mg Tablets
Like other prescription oncology medicines, abiraterone acetate can cause adverse effects. Possible side effects include:
High blood pressure
Low blood potassium levels
Fluid retention or swelling
Fatigue and weakness
Joint discomfort
Liver enzyme abnormalities
More serious complications can include liver injury, significant electrolyte disturbances, and cardiovascular problems. Regular blood pressure checks, blood tests, and clinical monitoring may be necessary.
Patients should seek prompt medical advice if they experience yellowing of the skin or eyes, severe weakness, palpitations, chest pain, or difficulty breathing. Do not change the dose or discontinue treatment without consulting the treating specialist.
Enquire About Xbira 250mg Tablets from Cordium Pharmaceuticals
For businesses searching for Xbira 250mg Tablets for pharmaceutical procurement in Singapore, Cordium Pharmaceuticals Pvt Ltd can be contacted for product documentation and supply-related enquiries. Availability, export eligibility, product authenticity, and shipping arrangements must be confirmed before an order is considered.
Singapore has specific requirements for therapeutic product registration, importation, and supply. Confirm that the product and proposed supply route comply with Health Sciences Authority (HSA) requirements before making procurement arrangements.
Frequently Asked Questions
1. What are Xbira 250mg Tablets used for?
They are associated with abiraterone acetate, a medicine used for certain forms of prostate cancer under specialist supervision. Confirm the specific product details before use.
2. Can I buy Xbira 250mg Tablets online in Singapore?
Prescription cancer medicines should be obtained through authorised healthcare channels. Check the product's registration and supply status with the relevant Singapore authorities before purchasing.
3. What are the common side effects?
Possible effects include fatigue, high blood pressure, fluid retention, low potassium, and liver abnormalities. Medical monitoring is important.
4. Does Cordium Pharmaceuticals supply Xbira 250mg internationally?
Contact Cordium Pharmaceuticals directly to verify current product availability, documentation, and eligibility for export to Singapore.
Medical disclaimer: This article is for educational and pharmaceutical procurement information only. It is not a substitute for medical advice, a prescription, or official product documentation. Product claims and regulatory status should be verified before publication and supply.
Xbira 250mg Tablets are associated with the active ingredient abiraterone acetate, an androgen biosynthesis inhibitor. Please verify the composition and strength against the actual product packaging and official product documentation before relying on this information.
Brand name: Xbira
Strength: 250mg
Dosage form: Oral tablets
Active ingredient: Abiraterone acetate, subject to product verification
Therapeutic category: Oncology
Primary treatment area: Certain forms of prostate cancer
Supply status: Subject to prescription, registration, and applicable import requirements
Abiraterone acetate is generally prescribed alongside prednisone or prednisolone and androgen deprivation therapy, depending on the patient's diagnosis and treatment plan. It must be used under specialist medical supervision.
Benefits and Uses of Xbira 250mg Tablets
Abiraterone acetate works by inhibiting CYP17, an enzyme involved in androgen production. Androgens, including testosterone, can stimulate the growth of prostate cancer cells. Reducing androgen production can therefore help control the disease in appropriate patients.
Potential clinical benefits include:
Prostate cancer management: Used for specific indications in advanced prostate cancer.
Hormonal treatment approach: Reduces androgen production through a targeted mechanism.
Combination therapy: May form part of a specialist-directed treatment regimen.
Ongoing disease management: Can help manage eligible patients when prescribed according to approved clinical indications.
Treatment response varies between patients. Xbira should not be described as a cure, and its suitability must be determined by an oncologist.
Possible Side Effects of Xbira 250mg Tablets
Like other prescription oncology medicines, abiraterone acetate can cause adverse effects. Possible side effects include:
High blood pressure
Low blood potassium levels
Fluid retention or swelling
Fatigue and weakness
Joint discomfort
Liver enzyme abnormalities
More serious complications can include liver injury, significant electrolyte disturbances, and cardiovascular problems. Regular blood pressure checks, blood tests, and clinical monitoring may be necessary.
Patients should seek prompt medical advice if they experience yellowing of the skin or eyes, severe weakness, palpitations, chest pain, or difficulty breathing. Do not change the dose or discontinue treatment without consulting the treating specialist.
Enquire About Xbira 250mg Tablets from Cordium Pharmaceuticals
For businesses searching for Xbira 250mg Tablets for pharmaceutical procurement in Singapore, Cordium Pharmaceuticals Pvt Ltd can be contacted for product documentation and supply-related enquiries. Availability, export eligibility, product authenticity, and shipping arrangements must be confirmed before an order is considered.
Singapore has specific requirements for therapeutic product registration, importation, and supply. Confirm that the product and proposed supply route comply with Health Sciences Authority (HSA) requirements before making procurement arrangements.
Frequently Asked Questions
1. What are Xbira 250mg Tablets used for?
They are associated with abiraterone acetate, a medicine used for certain forms of prostate cancer under specialist supervision. Confirm the specific product details before use.
2. Can I buy Xbira 250mg Tablets online in Singapore?
Prescription cancer medicines should be obtained through authorised healthcare channels. Check the product's registration and supply status with the relevant Singapore authorities before purchasing.
3. What are the common side effects?
Possible effects include fatigue, high blood pressure, fluid retention, low potassium, and liver abnormalities. Medical monitoring is important.
4. Does Cordium Pharmaceuticals supply Xbira 250mg internationally?
Contact Cordium Pharmaceuticals directly to verify current product availability, documentation, and eligibility for export to Singapore.
Medical disclaimer: This article is for educational and pharmaceutical procurement information only. It is not a substitute for medical advice, a prescription, or official product documentation. Product claims and regulatory status should be verified before publication and supply.
Keywords
